# Inside the Industry — Blog Post Template (Long-Form)

> **Format:** Full-length article for the Sageloom website blog (`company/Sageloom_Website/src/content/blogs/`)
> **Audience:** Students, faculty, practitioners, and hiring managers
> **Length:** 1,200–2,000 words
> **Purpose:** The canonical, comprehensive version of each company analysis. The LinkedIn post is a condensed version that links back here.

---

## YAML Frontmatter (Required by the Website Blog System)

```yaml
---
title: "Inside the Industry #[Number]: How [Company Name] Connects [Biology Focus] to [Computational Approach]"
date: YYYY-MM-DD
author: Sageloom Analytics Education Team
description: "A student-led analysis of [Company Name] — examining the pipeline from [biological problem] to [deliverable], and the skills required to work in this space."
tags:
  - inside-the-industry
  - bioinformatics
  - [additional topic tags]
series: "Inside the Industry"
---
```

---

## Article Structure

```markdown
# Inside the Industry #[Number]: How [Company Name] Connects [Biology Focus] to [Computational Approach]

*A student-led analysis by the Sageloom Analytics Education Team*

---

## The Company at a Glance

| | |
|---|---|
| **Company** | [Name] ([website link]) |
| **Industry** | [e.g., Clinical genomics, Precision oncology, Drug discovery] |
| **Core Problem** | [One sentence: the scientific/clinical problem they address] |
| **Key Technologies** | [e.g., NGS, Nextflow, GATK, Machine Learning] |
| **End Customer** | [e.g., Clinicians, Oncologists, Pharma R&D teams] |

---

## Why This Company Matters for Students

[2–3 paragraphs explaining why this company is worth studying. Not because they're famous — because their problem reveals something important about how bioinformatics works in production. Frame it around what students will learn, not company praise.]

---

## The Biological Challenge

[Deeper treatment than the LinkedIn post. Explain:]
- What biological question or clinical problem is being addressed?
- Why is this hard biologically? (specifics: allele frequencies, cellular heterogeneity, data noise, etc.)
- What prior knowledge is needed to understand the problem?
- What common misconceptions exist about this problem area?

---

## The Data Landscape

[This section is unique to the blog — not covered in the LinkedIn post.]
- What type of data does the company work with? (FASTQ, BAM, VCF, single-cell matrices, images, etc.)
- Where does the data come from? (sequencers, public databases, clinical samples)
- What makes this data challenging to work with? (scale, noise, missing labels, regulatory constraints)
- What databases or reference datasets are critical? (gnomAD, ClinVar, COSMIC, UniProt, etc.)

---

## The Computational Pipeline: End-to-End

[The core technical section. Walk through the pipeline step by step.]

### Input
- What enters the system? (raw data format, source)

### Processing & Analysis
- What are the major computational steps?
- What tools and algorithms are used at each stage?
- Where are the critical decision points in the pipeline?

### Output
- What does the customer actually receive?
- In what format? (PDF report, SaaS dashboard, VCF files, API)

[Include a pipeline diagram if available — even a simple text-based one:]

```
Raw Reads (FASTQ)
  → Alignment (BWA-MEM2)
  → Deduplication (Picard)
  → Variant Calling (GATK / Mutect2)
  → Annotation (VEP)
  → Filtering (Population DBs)
  → Clinical Classification (ACMG/AMP)
  → Diagnostic Report (PDF)
```

---

## AI and Machine Learning (If Applicable)

[Only include if the company uses AI/ML. If not, omit this section entirely — don't force it.]
- What specific problem does ML solve here?
- What type of model or approach? (CNN, transformer, random forest, etc.)
- What is the training data?
- How is the model validated?

---

## Teams and Roles: Who Builds This?

[This section matters for students thinking about careers. Describe the types of teams involved:]
- Bioinformatics / Computational Biology
- Software / Data Engineering
- Clinical / Regulatory
- Research / R&D
- Product / Commercial

[For each relevant team, briefly explain what they do and how they interact with the pipeline.]

---

## Skills Map: What You Need to Work Here

[Structured breakdown — this becomes a practical career reference for students.]

| Domain | Skills |
|--------|--------|
| **Biology** | [e.g., Variant interpretation, ACMG/AMP guidelines, somatic vs. germline oncology] |
| **Programming** | [e.g., Python (pysam, pandas), R, Bash scripting] |
| **Bioinformatics Tools** | [e.g., BWA-MEM2, GATK, Nextflow, Snakemake, samtools] |
| **Infrastructure** | [e.g., Docker, AWS/GCP, HPC, CI/CD] |
| **Statistics** | [e.g., Population genetics, FDR, Hardy-Weinberg] |
| **AI/ML** | [e.g., PyTorch, scikit-learn — only if applicable] |

---

## Industry Context

[Blog-only depth. How does this company fit in the broader landscape?]
- Who are the competitors or alternative approaches?
- What industry trend does this company represent?
- What regulatory or market forces shape their work?

---

## Critical Analysis

[Honest, balanced assessment — this is what makes Sageloom's content credible, not promotional.]
- What are the technical limitations of this approach?
- What assumptions does the company's pipeline depend on?
- What are the important trade-offs?
- What claims should be treated with caution?

---

## Key Takeaways

### Three Insights from This Analysis

1. [Insight about the biology-computation connection]
2. [Insight about the industry or career landscape]
3. [Insight about a tool, method, or approach]

### One Common Misconception

> [State a belief students might hold, then correct it with evidence.]

### One Skill Worth Learning After Reading This

> [Specific, actionable skill recommendation tied to the analysis.]

---

## Sources and Evidence

All claims in this analysis are based on publicly available information. We distinguish between:
- **Documented**: Directly stated by a reliable public source.
- **Inference**: Our interpretation based on available evidence.

| # | Source | Type |
|---|--------|------|
| 1 | [Source with DOI or URL] | Documented |
| 2 | [Source with DOI or URL] | Documented |
| 3 | [Source with DOI or URL] | Documented |
| 4 | [Interpretation description] | Inference |

---

*This analysis was conducted by the Sageloom Analytics student research cohort as part of the [Inside the Industry](link-to-series-page) initiative — a recurring program where students deconstruct real biotech and bioinformatics companies to understand how science, data, technology, and careers come together in the industry.*

*Have a company you think we should analyze next? [Contact us](link) or leave a comment on our [LinkedIn post](link-to-linkedin-post).*
```

---

## Pre-Publication Checklist

Before submitting this blog post to the Board via `request_confirmation`:

- [ ] **Factual accuracy:** All technical claims have cited sources.
- [ ] **Inference flagged:** Interpretations are clearly distinguished from documented facts.
- [ ] **No proprietary information:** Analysis uses only publicly available sources.
- [ ] **Zero hyperbole:** No promotional language about the analyzed company or Sageloom.
- [ ] **Student attribution:** Research cohort is credited appropriately.
- [ ] **YAML frontmatter complete:** title, date, author, description, tags, series.
- [ ] **Companion LinkedIn post drafted:** Short-form version references this blog URL.
- [ ] **Board approval gate:** Both blog post and LinkedIn draft submitted together.
